AI주식인사이트AI Stock Insight
B

애드바이오텍

179530KOSDAQ

61.3 / 100

Reference Date: 2026-09-08

Financial Score17.0 / 40
News Sentiment21.3 / 25
Momentum13.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Surged 19.8% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

AdvaTek is a biotech company developing eco-friendly products for livestock, aquaculture, and human use through technologies like IgY immune yolk antibodies, VHH nanobody antibodies, and microbial agents. Its IgY technology offers high titer and thermal stability, while VHH nanobodies provide strong tissue penetration and easy mass production, positioning them as promising alternatives to antibiotics and vaccines.

Number of Employees

64people

Average Salary

42.3M KRW

Score Calculation Basis

Detailed Financial Score

PER
—Industry Average 15.004.0Point
PBR
5.04Industry Average 1.200.0Point

4.2x industry avg (risky)

ROE
-40.31Industry Average 8.000.0Point

Well below industry avg

Debt Ratio
25.03Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20255.0 / 10 points
Revenue Growth Rate
2.5 / 3

Avg ▲11.1% (2-year basis)

Operating Profit Growth Rate
2.5 / 3

Avg ▲14.3% (2-year basis)

ROE Trend
0.0 / 4

Avg ROE -70.2% (declining, 3yr)

Detailed News Sentiment

4 totalPositive 4Neutral 0Negative 0Average Sentiment Score 85

Detailed Momentum

52-week position5.0Point

52w mid range (41%)

Current 2,515Won52-week high 4,17052-week low 1,350
1-month return6.0Point

1m +19.76% (strong rise)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

18 totalPositive 0Neutral 18Negative 0
  • Neutral전환청구권행사2026-09-04
  • Neutral[기재정정]주요사항보고서(자기전환사채매도결정)2026-09-03
  • Neutral[기재정정]주요사항보고서(전환사채권발행결정)2026-09-03
  • Neutral[기재정정]주요사항보고서(전환사채권발행결정)2026-09-03
  • Neutral전환청구권행사2026-09-01